Peripheral neuropathy,
Conditions
Interventions
meditation walk include 6 phase,
subject look video and walk together. Times for this intervention about 30 minutes/time,
3 times/weeks,
4 weeks.,walk with normal speed for 30 minutes/time,
Experimental Other,Active Comparator Other
Meditation walk,control
Sponsors
The graduate school of Srinakharinwirot University
Institute review board of Bankok
Eligibility
Sex/Gender
All
Age
40 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1.Never practice walking meditation. 2. The evaluated scores by the Michigan Neuropathy Screening Instrument (MNSI) in the section of a self-administered questionnaire have to be ≥7 points, and/or that in the section of clinical examination have to be ≥ 2points. 3. Able to walk independently without gait aids. 4. Able to understand and follow the instructions. 5. Be informed and sign the informed consent before the enrollment.
Exclusion criteria
Exclusion criteria: 1. The diseases that affect the central nervous system such as Parkinson's disease, hemiparesis, etc. 2. Partial or total amputation of lower extremities. 3. Body mass index (BMI) ≥ 40 kg/m2 4. Attend another exercise during the study. 5. Got a contraindicated complication for exercise as mentioned in the American Diabetes Association Guidelines such as systematic infection etc. 6. Uncontrolled hypertension, severe cardiovascular, severe respiratory conditions. 7. Severe foot problems that affect mobility or walking such as acute foot ulcer or foot condition that need orthotics or special shoes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Timed up and go test 4 weeks The test will be performed by asking subject to rise from a chair, walk three meters, turn, walk ba,Functional reach test 4 weeks The researcher will measure the displacement of reaching from the starting position to the maximum r,eye-open and eye-closed stand 4 weeks The time that subject can maintain balance will be recorded until a maximum of 30 seconds long. Subj | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of last dose of MPA before undergoing plasmapheresis 1 years MPA AUC | — |
Countries
Thailand
Contacts
Public ContactSuraphinit Saisathit
Outcome results
None listed